Goodman Advisory Group’s AbbVie ABBV Stock Holding History

Goodman Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44.6K	Hold	205	–	–	0.01%	117
2025 Q4	$46.8K	Sell	205 -633	-76%	-$144K	0.01%	103
2025 Q3	$194K	Sell	838 -488	-37%	-$99.4K	0.05%	71
2025 Q2	$246K	Sell	1,326 -18,469	-93%	-$3.43M	0.08%	51
2025 Q1	$4.15M	Buy	19,795 +2,295	+13%	+$446K	1.26%	30
2024 Q4	$3.11M	Buy	17,500 +1,966	+13%	+$361K	0.92%	34
2024 Q3	$3.07M	Buy	15,534 +1,620	+12%	+$302K	0.88%	34
2024 Q2	$2.39M	Buy	13,914 +13,567	+3,910%	+$2.25M	0.71%	34
2024 Q1	$63.2K	Hold	347	–	–	0.02%	96
2023 Q4	$53.8K	Hold	347	–	–	0.02%	91
2023 Q3	$51.7K	Sell	347 -134	-28%	-$19.7K	0.02%	93
2023 Q2	$64.8K	Hold	481	–	–	0.02%	80
2023 Q1	$76.7K	Buy	481 +134	+39%	+$20.5K	0.04%	68
2022 Q4	$56K	Hold	347	–	–	0.03%	71
2022 Q3	$47K	Hold	347	–	–	0.03%	73
2022 Q2	$53K	Buy	+347	New	+$53K	0.02%	75

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goodman Advisory Group's ABBV Position: Q1 2026 in Review

Goodman Advisory Group held its AbbVie (ABBV) position steady in Q1 2026 at 205 shares worth $44.6K. The position accounts for 0.01% of the portfolio, ranked #117.

Goodman Advisory Group first reported a position in ABBV in Q2 2022 and has held it in 16 quarters since. The position peaked at $4.15M in Q1 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Goodman Advisory Group held 205 shares of AbbVie worth $44.6K as of Q1 2026.
Goodman Advisory Group left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.01% of Goodman Advisory Group's portfolio in Q1 2026, its #117 holding.
Goodman Advisory Group first reported a position in AbbVie in Q2 2022 and has held it in 16 quarters since.
Goodman Advisory Group's AbbVie position peaked at $4.15M in Q1 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Goodman Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.